Skip to content

8hours Moisturization Potential of Syndent Soap Rose-GC-S118 and GC-S121

A Clinical study to Evaluate the 8hrs Moisturization Potential of Syndent Soap Rose-GC-S118 and GC-S121 - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/12/078337
Enrollment
32
Registered
2024-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product- Syndent Soap Rose-GC-S118 and GC-S121: Dose: Wash the area over one block on assigned (forearm) with the soap and water, rinse well. Route of Administration: Topical Durat

Sponsors

Wipro Yardley FZE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Gender: Male or Female with age 18-50. 2. Subjects willing to give written informed consent 3.Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4.Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events 5. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing mothers 2. Subject with oily skin or with too much Sweating 3. Have open sores or open lesions in the treatment area(s).. 4.Scars, excessive terminal hair or tattoo on the studied area 5.Henna tattoo anywhere on the body (in case of studies involving hair dyes) 6.Dermatological infection or pathology on the level of studied area 7.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 8.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 9.Chronic illness which may influence the outcome of the study 10.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 11.Have a known sensitivity to any of the constituents of the test product 12.Have not skin related issues

Design outcomes

Primary

MeasureTime frame
Change in hydrationTimepoint: T0min, T30min, T2Hours, T8Hours

Secondary

MeasureTime frame
Change in TEWLTimepoint: T0min, T30min, T8Hours

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026